loader
Please Wait
Applying Filters...

Parand Darou Pharma Parand Darou Pharma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for cep_2017_218___rev_02 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Asahi Kasei Finechem

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 ASAHI KASEI FINECHEM CO., LTD. Osaka JP (1)

    filter

    01 Cytarabine (1)

    filter

    01 Japan (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    ASAHI KASEI FINECHEM CO., LTD. Osak...

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Cytarabine

    PDF Supplier PDF
    URL Supplier Web Content
    CEP 2017-218 - Rev 02
    Valid
    Chemical
    2024-05-14
    760
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for CEP 2017-218 - Rev 02 of Asahi Kasei Finechem Co., Ltd. Osaka Jp

    Looking for Certificates of Suitability (CEPs) for CEP 2017-218 - Rev 02 of Asahi Kasei Finechem Co., Ltd. Osaka Jp 1

    20

    Asahi Kasei Finechem Co., Ltd. Osaka Jp, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their significant offerings is Cytarabine, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2017-218 - Rev 02

    This Chemical Type CEP, issued on May 14, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 760 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY